Searched for
ABBVIE ACQUISITION
Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...- Merck braces for Keytruda patent loss with $6.7 billion Terns betMerck is acquiring Terns Pharma for $6.7 billion to strengthen its cancer drug pipeline, aiming to reduce reliance on its blockbuster Keytr...
- Eli Lilly bets on next-generation cell therapy with $2.4 billion deal for OrnaEli Lilly will buy Orna Therapeutics for up to $2.4 billion in cash, gaining access to a technology that allows patients' own cells to gen...
- AbbVie in advanced talks to buy cancer drugmaker revolution medicines, shares jump nearly 30%AbbVie is in advanced talks to buy Revolution Medicines, a cancer drug company. The news pushed Revolution Medicines shares sharply higher....
- Bond markets are flooded with deals to fund M&ADemand has grown so fervent for corporate bonds that investors are once again willing to finance big mergers and acquisitions something the...
- Biocon Biologics launches biosimilar adalimumab in USAdalimumab is used to treat certain inflammatory diseases like rheumatoid arthritis. Humira contributed $21.2 billion in sales to AbbVie fo...
- Warren Buffett's Berkshire bought Activision shares before Microsoft takeoverBerkshire said that as of December 31, it owned 14.7 million shares worth about $975 million of the "Call of Duty" maker. Microsoft announc...
- Warren Buffett's Berkshire bought Activision shares before Microsoft takeoverInvestors monitor Berkshire's investments closely to see where Buffett and his investment managers Todd Combs and Ted Weschler see value.
- Hedge fund revival quickensEvent-driven funds handed investors a return of about 10% last year.
- Piramal Enterprises likely to hive off its critical care businessThe key driver is the valuation and if it does not match expectations, the deal may not move quickly,” an industry source, who claimed know...
- GlaxoSmithKline seeks FIPB nod to hike stake in Indian armGlaxoSmithKline has approached the FIPB to hike stake in its domestic arm by buying 24.33 per cent for an estimated Rs 6,400 crore.
Load More
